D.E. Shaw & Co’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $155K | Sell |
|
|||||
|
2024
Q3 | $869K | Buy |
|
|||||
|
2024
Q2 | $732K | Sell |
|
|||||
|
2024
Q1 | $1.45M | Buy |
|
|||||
|
2023
Q4 | $534K | Sell |
|
|||||
|
2023
Q3 | $835K | Buy |
|
|||||
|
2023
Q2 | $1.07M | Buy |
|
|||||
|
2023
Q1 | $2.14M | Buy |
|
|||||
|
2022
Q4 | $1.05M | Buy |
|
|||||
|
2022
Q3 | $785K | Buy |
|
|||||
|
2022
Q2 | $264K | Buy |
|
|||||
|
2022
Q1 | $251K | Sell |
|
|||||
|
2021
Q4 | $1.13M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $156K | Sell |
|
|||||
|
2020
Q4 | $21.4M | Sell |
|
|||||
|
2020
Q3 | $34.9M | Sell |
|
|||||
|
2020
Q2 | $56.3M | Buy |
|
|||||
|
2020
Q1 | $46.2M | Buy |
|
|||||
|
2019
Q4 | $45.3M | Buy |
|
|||||
|
2019
Q3 | $13.3M | Buy |
|
|||||
|
2019
Q2 | $4.82M | Buy |
|
|||||
|
2019
Q1 | $2.61M | Buy |
|
|||||
|
2018
Q4 | $1.59M | Sell |
|
|||||
|
2018
Q3 | $3.8M | Buy |
|
|||||
|
2018
Q2 | $2.91M | Sell |
|
|||||
|
2018
Q1 | $2.36M | Buy |
|
|||||
|
2017
Q4 | $699K | Buy |
|
|||||
|
2017
Q3 | $665K | Sell |
|
|||||
|
2017
Q2 | $676K | Sell |
|
|||||
|
2017
Q1 | $1.87M | Buy |
|
|||||
|
2016
Q4 | $387K | Buy |
|
|||||
|
2016
Q3 | $275K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $632K | Sell |
|
|||||
|
2015
Q3 | $513K | Buy |
|